دورية أكاديمية
Unique immune profiles in collaborative cross mice linked to survival and viral clearance upon infection.
العنوان: | Unique immune profiles in collaborative cross mice linked to survival and viral clearance upon infection. |
---|---|
المؤلفون: | Graham JB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Swarts JL; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Leist SR; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Schäfer A; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Bell TA; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Hock P; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Farrington J; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Shaw GD; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Ferris MT; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Pardo-Manuel de Villena F; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Baric RS; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Lund JM; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Global Health, University of Washington, Seattle, WA, USA. |
المصدر: | IScience [iScience] 2024 Feb 02; Vol. 27 (3), pp. 109103. Date of Electronic Publication: 2024 Feb 02 (Print Publication: 2024). |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE |
أسماء مطبوعة: | Original Publication: [Cambridge, MA] : Cell Press, [2018]- |
مستخلص: | The response to infection is generally heterogeneous and diverse, with some individuals remaining asymptomatic while others present with severe disease or a diverse range of symptoms. Here, we address the role of host genetics on immune phenotypes and clinical outcomes following viral infection by studying genetically diverse mice from the Collaborative Cross (CC), allowing for use of a small animal model with controlled genetic diversity while maintaining genetic replicates. We demonstrate variation by deeply profiling a broad range of innate and adaptive immune cell phenotypes at steady-state in 63 genetically distinct CC mouse strains and link baseline immune signatures with virologic and clinical disease outcomes following infection of mice with herpes simplex virus 2 (HSV-2) or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This work serves as a resource for CC strain selection based on steady-state immune phenotypes or disease presentation upon viral infection, and further, points to possible pre-infection immune correlates of survival and early viral clearance upon infection. Competing Interests: S.R.L. and R.S.B. are listed on a patent for the SARS-CoV-2 MA10 virus (US 11225508 B1, “Mouse-adapted SARS-CoV-2 viruses and methods of use thereof”). Funding for this study was provided by NIH grant U19 AI100625 (to R.S.B.), R01 AI157253 (to R.S.B.), P01 AI132130 (to M.T.F. and F.P.M.d.V.), and R21 AI152559 (to J.M.L.). (© 2024 The Author(s).) |
References: | Proc Natl Acad Sci U S A. 2021 Mar 9;118(10):. (PMID: 33649222) Nat Genet. 2004 Nov;36(11):1133-7. (PMID: 15514660) Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13498-503. (PMID: 23898211) mBio. 2016 Sep 20;7(5):. (PMID: 27651361) J Clin Invest. 2009 Nov;119(11):3266-77. (PMID: 19855131) PLoS Pathog. 2021 Jan 29;17(1):e1009287. (PMID: 33513210) PLoS Pathog. 2013 Feb;9(2):e1003196. (PMID: 23468633) Immunohorizons. 2022 Jan 14;6(1):8-15. (PMID: 35031582) J Immunol. 2012 Mar 15;188(6):2516-23. (PMID: 22308307) J Immunol. 2012 Dec 15;189(12):5924-33. (PMID: 23129753) Nature. 2020 Oct;586(7830):560-566. (PMID: 32854108) J Virol. 2009 Apr;83(7):3019-28. (PMID: 19153229) Blood. 2009 May 28;113(22):5488-96. (PMID: 19234143) J Immunol. 2013 Mar 1;190(5):1936-47. (PMID: 23355737) Elife. 2022 Feb 03;11:. (PMID: 35112666) iScience. 2021 Mar 01;24(4):102255. (PMID: 33817568) Cell. 2020 Nov 12;183(4):1070-1085.e12. (PMID: 33031744) J Immunol. 2004 Apr 1;172(7):4123-32. (PMID: 15034024) J Immunol. 2020 Jul 1;205(1):3-11. (PMID: 32571979) J Exp Med. 2007 Sep 3;204(9):2159-69. (PMID: 17709423) Mamm Genome. 2012 Oct;23(9-10):706-12. (PMID: 22847377) Immun Ageing. 2018 Aug 08;15:17. (PMID: 30093911) J Immunol. 2001 Dec 15;167(12):6834-40. (PMID: 11739500) PLoS Genet. 2015 Oct 09;11(10):e1005504. (PMID: 26452100) Cell Rep. 2017 Nov 21;21(8):2313-2325. (PMID: 29166619) J Immunol. 2013 Jun 15;190(12):6115-25. (PMID: 23667113) Science. 2008 May 30;320(5880):1220-4. (PMID: 18436744) BMC Genomics. 2016 Feb 27;17:143. (PMID: 26921172) J Exp Med. 2009 Feb 16;206(2):435-48. (PMID: 19188498) Nat Rev Immunol. 2022 Aug;22(8):484-498. (PMID: 34815556) Science. 2014 Nov 21;346(6212):987-91. (PMID: 25359852) Nat Immunol. 2021 Dec;22(12):1479-1489. (PMID: 34795445) Annu Rev Immunol. 2021 Apr 26;39:417-447. (PMID: 33902312) Cell Host Microbe. 2019 Apr 10;25(4):484-498. (PMID: 30974083) BMC Genet. 2015 Aug 28;16:106. (PMID: 26310945) J Immunol. 2007 Jun 15;178(12):7511-5. (PMID: 17548583) J Clin Invest. 2023 May 15;133(10):. (PMID: 36951943) J Immunol. 2010 Aug 15;185(4):2382-92. (PMID: 20639494) Cell Rep. 2020 Apr 14;31(2):107508. (PMID: 32294433) J Virol. 2010 Sep;84(17):8790-8. (PMID: 20573822) Nat Genet. 2020 Oct;52(10):1036-1045. (PMID: 32929287) J Immunol. 2019 Feb 1;202(3):777-786. (PMID: 30587532) Nat Immunol. 2005 Apr;6(4):353-60. (PMID: 15785761) Sci Rep. 2016 May 19;6:26437. (PMID: 27193691) PLoS Pathog. 2016 Nov 2;12(11):e1005996. (PMID: 27806117) PLoS Pathog. 2022 Jul 14;18(7):e1010649. (PMID: 35834486) Nature. 2002 Dec 5;420(6915):502-7. (PMID: 12466842) J Immunol. 2013 Apr 1;190(7):3438-46. (PMID: 23467933) mBio. 2015 May 05;6(3):e00493-15. (PMID: 25944860) mBio. 2022 Aug 30;13(4):e0145422. (PMID: 35862771) |
فهرسة مساهمة: | Keywords: Immunology; Virology |
تواريخ الأحداث: | Date Created: 20240216 Latest Revision: 20240217 |
رمز التحديث: | 20240217 |
مُعرف محوري في PubMed: | PMC10867580 |
DOI: | 10.1016/j.isci.2024.109103 |
PMID: | 38361611 |
قاعدة البيانات: | MEDLINE |
تدمد: | 2589-0042 |
---|---|
DOI: | 10.1016/j.isci.2024.109103 |